Family Medicine · Glendale, CA
NPI
1821014085
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
247 W Glenoaks Blvd
Glendale, CA, 91202
Phone (818) 843-8555
Groups this clinician bills Medicare through
Medicare paid, 2024
$255K
4,683 services
Medicare patients, 2024
582
Average age 77
Drug cost, 2024
$5.4M
35,544 prescriptions
Company payments, 2025
$2,887
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Azat Bogikian was code 99213 (office e&m - established), 2,899 times for 510 patients. In total Azat Bogikian billed 4,683 services in 37 codes, and Medicare paid $255K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,899 | 510 | $66.12 | $192K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 341 | 341 | $19.25 | $6,564 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 214 | 37 | $0.76 | $162 |
| 96372 Injection Administration | Office | 160 | 80 | $10.96 | $1,754 |
| 99308 SNF E&M | Facility | 139 | 36 | $52.20 | $7,256 |
| 99309 SNF E&M | Facility | 116 | 33 | $82.54 | $9,575 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 100 | 55 | $41.42 | $4,142 |
| G0008 Administration of influenza virus vaccine | Office | 86 | 86 | $34.30 | $2,950 |
| 90658 Vaccine Product | Office | 86 | 86 | $21.42 | $1,842 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 67 | 64 | $12.47 | $835 |
| 93000 Electrocardiogram | Office | 64 | 58 | $11.32 | $724 |
| 99306 SNF E&M | Facility | 60 | 44 | $135.51 | $8,130 |
| 69210 Other Organ Systems | Office | 55 | 51 | $37.66 | $2,071 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 51 | 33 | $32.98 | $1,682 |
| 99203 Office E&M - New | Office | 50 | 50 | $57.77 | $2,889 |
By year: 2022 $253K for 4,047 services; 2023 $267K for 4,367 services; 2024 $255K for 4,683 services.
Medicare prescription drug claims, 2024
In 2024, the drug Azat Bogikian prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,465 prescriptions and refills. In total Azat Bogikian wrote 35,544 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,465 | 1,981 | 225 | $7,637 |
| Amlodipine Besylate Generic | 1,424 | 1,826 | 184 | $3,023 |
| Rosuvastatin Calcium Generic | 1,171 | 1,412 | 149 | $5,643 |
| Losartan Potassium Generic | 902 | 1,075 | 107 | $3,515 |
| Levothyroxine Sodium Generic | 680 | 907 | 83 | $4,657 |
| Vascepa Icosapent Ethyl | 672 | 727 | 83 | $238K |
| Omeprazole Generic | 670 | 831 | 98 | $2,409 |
| Jardiance Empagliflozin | 661 | 734 | 83 | $430K |
| Tamsulosin Hcl Generic | 626 | 789 | 85 | $4,813 |
| Escitalopram Oxalate Generic | 571 | 670 | 76 | $2,243 |
| Gabapentin Generic | 567 | 672 | 78 | $2,770 |
| Meclizine Hcl Generic | 559 | 617 | 68 | $2,866 |
| Clonidine Hcl Generic | 551 | 611 | 74 | $1,109 |
| Metformin Hcl Generic | 540 | 721 | 80 | $9,220 |
| Metoprolol Succinate Generic | 527 | 686 | 79 | $3,813 |
Brand drugs: 8,082 claims; generic drugs: 26,672 claims; opioid claims: 167.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Azat Bogikian $2,887 ($2,887 in general payments such as food, travel and fees) from 22 companies. The largest payer was Amgen Inc. with $372.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 13 | $372 |
| Novo Nordisk Inc NVO | 11 | $357 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $233 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $232 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $208 |
| Shield Therapeutics Inc STX.L | 14 | $174 |
| Lilly USA, LLC LLY | 8 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $140 |
| Ardelyx, Inc. ARDX | 5 | $137 |
| Axsome Therapeutics, Inc. AXSM | 4 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.